Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus

By Neuser Dieter  

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 579-587

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen  

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Evaluation of the Efficacy and Tolerability of Acarbose in Patients with Diabetes Mellitus: A Postmarketing Surveillance Study

By Spengler M.   Schmitz H.   Landen H.  

Clinical Drug Investigation, Vol. 25, Iss. 10, 2005-01 ,pp. : 651-659

Adis International

Access to resources Recommend Favorite

Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy

By Bachmann W.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 679-686

Adis International

Access to resources Recommend Favorite

Post-Marketing Surveillance of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus and Subjects with Impaired Glucose Tolerance in China

By Pan Chang-Yu  

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 397-405

Adis International

Access to resources Recommend Favorite